Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, and non-destructive, so the description adds significant context: it explains data sources (SEC EDGAR/XBRL, FAERS), handling of off-calendar fiscal years, sorting by primary metric, and returns paired data with citation URIs. This goes well beyond annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but each sentence provides value: query examples, preference rule, data sources, sorting behavior, and return format. It is not excessively long for a tool with two distinct types, though it could be slightly more streamlined.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema exists, so the description appropriately mentions return values ('paired data + pipeworx:// citation URIs per entity') and data specifics. It covers the main behaviors but could be slightly more explicit about the exact output shape or edge cases.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. The description adds extra meaning by detailing what data each 'type' retrieves (e.g., revenue, net income for company; adverse-event counts for drug) and mentions that results are sorted by primary metric, which is not in the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states that the tool performs side-by-side comparisons of 2–5 companies or drugs in a single call, using explicit query examples like 'X vs Y' and 'rank these companies'. It distinguishes itself from sibling tools by specifying the exact purpose and scope.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', providing strong when-to-use guidance. It also clarifies what each type (company/drug) pulls, but does not explicitly name alternative tools or state when not to use it beyond the preference statement.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions, while the polymarket_edges, polymarket_arbitrage, and related tools blur edge-detection boundaries. The server's Bitstamp identity also clashes with the bulk of tools being unrelated data-research, making selection harder.

Naming Consistency3/5

Tool names are all lowercase snake_case, which is consistent formatting, but no coherent verb_noun pattern emerges. Some are verb-first (ask_pipeworx, compare_entities, discover_tools) while others are noun-first or resource-based (ticker_hour, order_book, polymarket_edges), and the naming style differs across the two major domains.

Tool Count2/5

At 38 tools, the set is well over the 15-tool threshold for a focused server, and the majority of tools are unrelated to the server's Bitstamp name. The count feels bloated and scattershot—it would be better split into separate data-research and exchange servers.

Completeness3/5

The data-research and question-answering surface is broadly covered, with meta-tools and validation. However, the Bitstamp exchange half is incomplete: it only provides public market data (ticker, order book, trades, OHLC) with no trading, account, or private-data operations, an obvious gap given the server's name.